Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al B Benson

Showing results (251-260 of 350) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communicationNeal J Meropol, Kevin P Weinfurt, Caroline B Burnett, et al.
JCO Oncology Practice|January 11, 2023
An Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical TrialsNadine J Barrett, Leigh Boehmer, Janelle Schrag, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 20, 2013
Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: a mediational modelSharon Manne, Deborah Kashy, Terrance Albrecht, et al.
Journal of the National Cancer Institute|April 22, 2026
Integrating oncology advanced practice providers and clinical pharmacists into clinical cancer researchChrista Braun-Inglis, Jamie Myers, Bridget O'Brien, et al.
BMC Cancer|May 19, 2011
Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology GroupHarry H Yoon, Paul J Catalano, Kathleen M Murphy, et al.
Journal of the National Cancer Institute|August 19, 2011
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803Kimmie Ng, Shuji Ogino, Jeffrey A Meyerhardt, et al.
Journal of the National Cancer Institute|November 30, 2014
Aspirin and COX-2 inhibitor use in patients with stage III colon cancerKimmie Ng, Jeffrey A Meyerhardt, Andrew T Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
90Y-edotreotide for metastatic carcinoid refractory to octreotideDavid L Bushnell, Thomas M O'Dorisio, M Sue O'Dorisio, et al.
Pancreas|December 6, 2012
Systemic treatment in unresectable metastatic well-differentiated carcinoid tumors: consensus results from a modified delphi processJonathan R Strosberg, George A Fisher, Al B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2026
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Kristen K Ciombor, Lianchun Xiao, et al.
Pageof 35

Showing results (251-260 of 350) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communicationNeal J Meropol, Kevin P Weinfurt, Caroline B Burnett, et al.
JCO Oncology Practice|January 11, 2023
An Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical TrialsNadine J Barrett, Leigh Boehmer, Janelle Schrag, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 20, 2013
Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: a mediational modelSharon Manne, Deborah Kashy, Terrance Albrecht, et al.
Journal of the National Cancer Institute|April 22, 2026
Integrating oncology advanced practice providers and clinical pharmacists into clinical cancer researchChrista Braun-Inglis, Jamie Myers, Bridget O'Brien, et al.
BMC Cancer|May 19, 2011
Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology GroupHarry H Yoon, Paul J Catalano, Kathleen M Murphy, et al.
Journal of the National Cancer Institute|August 19, 2011
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803Kimmie Ng, Shuji Ogino, Jeffrey A Meyerhardt, et al.
Journal of the National Cancer Institute|November 30, 2014
Aspirin and COX-2 inhibitor use in patients with stage III colon cancerKimmie Ng, Jeffrey A Meyerhardt, Andrew T Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
90Y-edotreotide for metastatic carcinoid refractory to octreotideDavid L Bushnell, Thomas M O'Dorisio, M Sue O'Dorisio, et al.
Pancreas|December 6, 2012
Systemic treatment in unresectable metastatic well-differentiated carcinoid tumors: consensus results from a modified delphi processJonathan R Strosberg, George A Fisher, Al B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2026
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Kristen K Ciombor, Lianchun Xiao, et al.
Pageof 35